| Application no. and date | 16794479.2 (espacenet) (Federated) (European Patent Register), 20161028 | | Patent/reg. no. and date | DK/EP 3368534, 20210127 | | Publication date | 20180905 | | Priority no. and date | US 201562249074 P, 20151030 | | EP pub. no. and date |
EP 3368534 20180905 | | Effective date | | | Applicant/owner | NEUROCRINE BIOSCIENCES, INC., 12780 El Camino Real
San Diego, CA 92130, US | | Applicant ref. no. | V52013DK00 | | Inventor | ZOOK, Scott, 3716 Arizona Street
San Diego, CA 92104, US,
CARR, Andrew, 91 Lancaster Gate
Upper Cambourne
Cambridge CB23 6AU, GB,
BONNAUD, Thierry, 17 Sunmead Walk
Cambridge CB19YB, GB,
MCGEE, Kevin, 82663 Marlow Road
Eugene, OR 97405, US | | Representative | Zacco Denmark A/S, Arne Jacobsens Allé 15, 2300 København S | | Opponent | | | IPC Class | A61K 31/4375 (2006.01) , A61P 25/00 (2006.01) , C07D 471/04 (2006.01) | | Title | VALBENAZIN-DITOSYLAT OG POLYMORFER DERAF | | Int. application no. | US2016059306 | | Int. publication no. | WO2017075340 | | Related patent (certificate) | | | Status | DK/EP patent | | Pædiatrisk forlængelse | - | | Udløbsdato for pædiatrisk forlængelse | - |
|
